Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Internal Medicine Physician in Denver, CO
NPI: 1104112515Primary Practice Location
HealthONE Clinic Services - Oncology Hematology LLC
1721 E 19th Ave, Denver, CO
Primary Employer
HealthONE Clinic Services - Oncology Hematology LLC
bloodcancerinstitute.com
HQ Phone
Get M.D. Henning's Phone Numberphone_androidMobile
Get M.D. Henning's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCO State Medical License
SC State Medical License
CO State Medical License
2016 - 2027
MT State Medical License
2019 - 2026
WY State Medical License
2025 - 2025
SC State Medical License
2011 - 2014
American Board of Internal Medicine
Medical Oncology
Medical University of South Carolina (MUSC)
medicine.musc.edu
Residency • Internal Medicine
2011 - 2014
University of Kiel Faculty of Medicine
Medical School
Until 2006
Univ Kiel- Christian- Albrechts- Fac Med
Medical School
Until 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 98 | 298 |
| 2 | 36415Insertion of needle into vein for collection of blood sample | 77 | 516 |
| 3 | 96365Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 60 | 97 |
| 4 | 96401Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | 51 | 126 |
| 5 | 96366Infusion into a vein for therapy, prevention, or diagnosis | 39 | 132 |
Plasma cell disorders in HIV-infected patients: epidemiology and molecular mechanisms.
Authors: Yubin Kang, Ashley Jeter
Publication Date: 2012-11-07
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: Dexamethasone, DRUG: Pomalidomide, DRUG: Bortezomib, DRUG: Belantamab mafodotin
Lead Sponsor: Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Intervention / Treatment: DRUG: MK-4002
Lead Sponsor: Washington University School of Medicine
Collaborators: Bristol-Myers Squibb, Celgene
Intervention / Treatment: DRUG: Dexamethasone, DRUG: Pomalidomide, DRUG: Elotuzumab
